Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI

NCT00176592 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Betaseron
DRUG: Copaxone

Sponsor

University of Medicine and Dentistry of New Jersey